Enhanced recovery after cleft palate repair : A quality improvement project
© 2022 John Wiley & Sons Ltd..
BACKGROUND: Children undergoing cleft palate repair present challenges to postoperative management due to several factors that can complicate recovery. Utilization of multimodal analgesic protocols can improve outcomes in this population. We report experience designing and implementing an enhanced recovery after surgery (ERAS) pathway for cleft palate repair to optimize postoperative recovery.
AIMS: The primary aim was to implement an ERAS pathway with >70% bundle adherence to achieve a 30% reduction in postoperative opioid consumption within 12 months. Our secondary aims assessed intraoperative opioid consumption, length of stay, timeliness of oral intake, and respiratory recovery.
METHODS: A multidisciplinary team of perioperative providers developed an ERAS pathway for cleft palate patients. Key drivers included patient and provider education, formal pathway creation and implementation, multimodal pain therapy, and target-based care. Interventions included maxillary nerve blockade and enhanced intra- and postoperative medication regimens. Outcomes were displayed as statistical process control charts.
RESULTS: Pathway compliance was 77.0%. Patients during the intervention period (n = 39) experienced a 49% reduction in postoperative opioid consumption (p < .0001) relative to our historical cohort (n = 63), with a mean difference of -0.33 ± 0.11 mg/kg (95% CI -0.55 to -0.12 mg/kg). Intraoperative opioid consumption was reduced by 36% (p = .002), with a mean difference of -0.27 ± 0.09 mg/kg (95% CI -0.45 to -0.09 mg/kg). Additionally, patients in the intervention group had a 45% reduction in time to first oral intake (p = .02) relative to our historical cohort, with a mean difference of -3.81 ± 1.56 h (95% CI -6.9 to -0.70). There was no difference in PACU or hospital length of stay, but there was a significant reduction in variance of all secondary outcomes.
CONCLUSION: Opioid reduction and improved timeliness of oral intake is possible with an ERAS protocol for cleft palate repair, but our protocol did not alter PACU or hospital length of stay.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Paediatric anaesthesia - 32(2022), 10 vom: 05. Okt., Seite 1104-1112 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Esfahanian, Mohammad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analgesics, Opioid |
|---|
| Anmerkungen: |
Date Completed 13.09.2022 Date Revised 27.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pan.14541 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344488691 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344488691 | ||
| 003 | DE-627 | ||
| 005 | 20231226022904.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pan.14541 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1148.xml |
| 035 | |a (DE-627)NLM344488691 | ||
| 035 | |a (NLM)35929340 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Esfahanian, Mohammad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhanced recovery after cleft palate repair |b A quality improvement project |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.09.2022 | ||
| 500 | |a Date Revised 27.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: Children undergoing cleft palate repair present challenges to postoperative management due to several factors that can complicate recovery. Utilization of multimodal analgesic protocols can improve outcomes in this population. We report experience designing and implementing an enhanced recovery after surgery (ERAS) pathway for cleft palate repair to optimize postoperative recovery | ||
| 520 | |a AIMS: The primary aim was to implement an ERAS pathway with >70% bundle adherence to achieve a 30% reduction in postoperative opioid consumption within 12 months. Our secondary aims assessed intraoperative opioid consumption, length of stay, timeliness of oral intake, and respiratory recovery | ||
| 520 | |a METHODS: A multidisciplinary team of perioperative providers developed an ERAS pathway for cleft palate patients. Key drivers included patient and provider education, formal pathway creation and implementation, multimodal pain therapy, and target-based care. Interventions included maxillary nerve blockade and enhanced intra- and postoperative medication regimens. Outcomes were displayed as statistical process control charts | ||
| 520 | |a RESULTS: Pathway compliance was 77.0%. Patients during the intervention period (n = 39) experienced a 49% reduction in postoperative opioid consumption (p < .0001) relative to our historical cohort (n = 63), with a mean difference of -0.33 ± 0.11 mg/kg (95% CI -0.55 to -0.12 mg/kg). Intraoperative opioid consumption was reduced by 36% (p = .002), with a mean difference of -0.27 ± 0.09 mg/kg (95% CI -0.45 to -0.09 mg/kg). Additionally, patients in the intervention group had a 45% reduction in time to first oral intake (p = .02) relative to our historical cohort, with a mean difference of -3.81 ± 1.56 h (95% CI -6.9 to -0.70). There was no difference in PACU or hospital length of stay, but there was a significant reduction in variance of all secondary outcomes | ||
| 520 | |a CONCLUSION: Opioid reduction and improved timeliness of oral intake is possible with an ERAS protocol for cleft palate repair, but our protocol did not alter PACU or hospital length of stay | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a analgesics-opioid | |
| 650 | 4 | |a cleft palate | |
| 650 | 4 | |a enhanced recovery after surgery | |
| 650 | 4 | |a length of stay | |
| 650 | 4 | |a maxillary nerve | |
| 650 | 4 | |a pain-postoperative | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 700 | 1 | |a Marcott, Stephen Craig |e verfasserin |4 aut | |
| 700 | 1 | |a Hopkins, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Burkart, Brendan |e verfasserin |4 aut | |
| 700 | 1 | |a Khosla, Rohit Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Lorenz, H Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a De Souza, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Algaze-Yojay, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Caruso, Thomas J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Paediatric anaesthesia |d 1997 |g 32(2022), 10 vom: 05. Okt., Seite 1104-1112 |w (DE-627)NLM074660497 |x 1460-9592 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2022 |g number:10 |g day:05 |g month:10 |g pages:1104-1112 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pan.14541 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2022 |e 10 |b 05 |c 10 |h 1104-1112 | ||